Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes

Vaccine

Volumn 27, Issue 7, 2009, Pages 1032-1039

  Arankalle, Vidya A ^a   Lole, Kavita S ^a   Deshmukh, Tejaswini M ^a   Srivastava, Shubham ^a   Shaligram, Umesh S ^b  

^a NATIONAL INSTITUTE OF VIROLOGY   (India)

^b Serum Institute of India Ltd   (India)

Author keywords

Candidate vaccine efficacy; DNA protein liposomes; Hepatitis E; Rhesus monkeys

Indexed keywords

CAPSID PROTEIN; DNA; EPITOPE; HEPATITIS E VACCINE; LIPOSOME; NEUTRALIZING EPITOPE; ORF2 PROTEIN; PLASMID DNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; HEPATITIS E; IMMUNIZATION; IMMUNOGENICITY; LIPOSOMAL DELIVERY; NONHUMAN; ORF2 GENE; PRIORITY JOURNAL; PROKARYOTE; PROTEIN EXPRESSION; RHESUS MONKEY; SEROCONVERSION; VIRUS GENE; VIRUS REPLICATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; IMMUNIZATION, SECONDARY; LIPOSOMES; MACACA MULATTA; MICE; VACCINES, DNA; VACCINES, SUBUNIT; VIRAL HEPATITIS VACCINES; VIRAL PROTEINS;

EID: 58549097437     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.11.097     Document Type: Article

References (24)

1. Khuroo M.S., Teli R.T., Skidmore S., Sofi M.A., and Khuroo H.I. Incidence and severity of viral hepatitis in pregnancy. Am J Med 70 (1981) 252-255
2. Boccia D., Guthmann J., Klovstad H., Hamid N., Tatay M., Ciglenecki I., et al. High mortality associated with an outbreak of Hepatitis E among displaced persons in Darfur, Sudan. Clin Infect Dis 42 (2006) 1679-1684
3. Arankalle V.A., Jha J., Favorov M.O., Chaudhari A., Fields A.H., and Banerjee K. Contribution of HEV and HCV in causing fulminant non-A, non-B hepatitis in Western India. J Viral Hepat 2 (1995) 189-193
4. Drobeniuc J., Favorov M.O., Shapiro C.N., Bell B.P., Mast E.E., Dadu A., et al. Hepatitis E virus antibody prevalence among persons who work with swine. J Infect Dis 184 (2001) 1594-1597
5. Meng X.J., Halbur P.G., Shapiro M.S., Govindarajan S., Bruna J.D., Mushahwar I.K., et al. Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol 72 (1998) 9714-9721
6. Tamada Y., Yano K., Yatsuhashi H., Inoue O., Mawatari F., and Ishibashi H. Consumption of wild boar linked to cases of hepatitis E. J Hepatol 40 (2004) 869-870
7. Tei S., Kitajima N., Ohara S., Inoue Y., Miki M., Yamatani T., et al. Consumption of uncooked deer meat as a risk factor for hepatitis E virus infection: an age and sex-matched case-control study. J Med Virol 74 (2004) 67-70
8. Yazaki Y., Mizuo H., Takahashi M., Nishizawa T., Sasaki N., Gotanda Y., et al. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J Gen Virol 84 (2003) 2351-2357
9. Viswanathan R., and Naidu S. Infectious hepatitis in Delhi 1955-1956: a critical study; observations in pregnant women. Indian J Med Res 45 Suppl. 1 (1957) 1-30
10. Tsarev S.A., Tsareva T.S., Emerson S.U., Govindarajan S., Shapiro M., Gerin J.L., et al. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. Vaccine 15 (1997) 1834-1838
11. Li S.W., Zhang J., Li Y.M., Ou S.H., Huang G.Y., He Z.Q., et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 23 (2005) 2893-2901
12. Kamili S., Spelbring J., and Krawczynski K. DNA vaccination against hepatitis E virus infection in cynomolgus macaques. J Gastroenterol Hepatol 17 Suppl. 3 (2002) S365-S369
13. Kamili S., Spelbring J., Carson D., and Krawczynski K. Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection. J Infect Dis 189 (2004) 258-264
14. Shrestha M.P., Scott R.M., Shrestha S.K., Myint K.S.A., Mammen M.P., Joshi D.M., et al. Safety and efficacy of a hepatitis E virus vaccine. N Engl J Med 356 (2007) 895-903
15. Deshmukh T.M., Lole K.S., Tripathy A.S., and Arankalle V.A. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice. Vaccine 25 (2007) 4350-4360
16. Gregoriadis G., McCormack B., Obrenovic M., Saffie R., Zadi B., and Perrie Y. Vaccine entrapment in liposomes. Methods 19 (1999) 156-162
17. Arankalle V.A., Lole K.S., Deshmukh T.M., Chobe L.P., and Gandhe S.S. Evaluation of human (genotype 1) and swine (genotype 4)-ORF-2 based ELISAs for anti-HEV IgM and IgG detection in an endemic country and search for type 4 human HEV infections. J Viral Hepat 14 (2007) 435-445
18. Li F., Torresi J., Locarnini S.A., Zhuang H., Zhu W., Guo X., et al. Amino-terminal epitopes are exposed when full-length open reading frame 2 of hepatitis E virus is expressed in Escherichia coli, but carboxy-terminal epitopes are masked. J Med Virol 52 (1997) 289-300
19. Arankalle V.A., Chobe L.P., Joshi M.V., Chadha M.S., Kundu B., and Walimbe A.M. Human and swine hepatitis E viruses from Western India belong to different genotypes. J Hepatol 36 (2002) 417-425
20. Zhou Y.H., Purcell R.H., and Emerson S.U. An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4. Vaccine 22 (2004) 2578-2585
21. Zhou Y.H., Purcell R.H., and Emerson S.U. A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus. Vaccine 2 23 (2005) 3157-3165
22. Purcell R.H., Nguyen H., Shapiro M., Engle R.E., Govindarajan S., Blackwelder W.C., et al. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine 21 (2003) 2607-2615
23. Zhang M., Emerson S., Nguyen H., Engle R., Govindarajan S., Blackwelder W., et al. Recombinant vaccine against hepatitis E: duration of protective immunity in Rhesus macaques. Vaccine 20 (2002) 3285-3291
24. Robinson R.A., Burgess W.H., and Emerson S.U. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells. Protein Expr Purif 12 (1998) 75-84